Strekin
Basel
About Strekin
Strekin is a clinical-stage biopharmaceutical company headquartered in Basel, Switzerland. Strekin was founded in 2014 by Dr. Alexander Bausch, Prof. Dr. Daniel Bodmer, and Mr. Roger Meier.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2019)
- Website: strekin.com
- Phone: +41 616332971
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/strekin-67854 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.